CRNO B — Cereno Scientific AB Income Statement
0.000.00%
Last trade - 00:00
- SEK911.26m
- SEK869.49m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue | |||||
Gross Profit | 10.9 | 8.22 | 44.8 | 57.5 | — |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 13.1 | 15.7 | 15 | 27.5 | 44.7 |
Operating Profit | -13.1 | -15.7 | -15 | -27.5 | -44.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -15.3 | -16 | -16.3 | -27.6 | -48.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -15.3 | -16 | -16.3 | -27.7 | -48.1 |
Net Income Before Extraordinary Items | |||||
Net Income | -15.3 | -16 | -16.3 | -27.7 | -48.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -15.3 | -16 | -16.3 | -27.7 | -48.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.38 | -0.223 | -0.154 | -0.201 | -0.206 |
Dividends per Share |